Zobrazeno 1 - 2
of 2
pro vyhledávání: '"J. P. Wersall"'
Autor:
H. Mellstedt, Jan Fagerberg, J.-E. Frödin, A.-L. Hjelm, K. Ericson, K. Merk, J. P. Wersall, B. Kalin, Peter Ragnhammar, G. Masucci, Christina Lindemalm
Publikováno v:
Medical Oncology and Tumor Pharmacotherapy. 10:103-111
Pretreatment with a low dose of cyclophosphamide (CY) has been claimed to inhibit suppressor functions and augment various immune functions. A combination of a low dose of CY, alpha-interferon (IFN-alpha) and continuous infusion of interleukin-2 (IL-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0803cfd1ca601530d720933289d3067
https://doi.org/10.1007/bf02987776
https://doi.org/10.1007/bf02987776
Autor:
I. Magnusson, J. P. Wersall, H. Mellstedt, Shetye J, Peter Ragnhammar, J.-E. Frödin, R. Svanstrom, Jan Fagerberg, A.-L. Hjelm
Publikováno v:
Cancer biotherapy. 10(1)
Subcutaneous administration of low doses of recombinant interleukin-2 (IL-2) and interferon-alpha (IFN-alpha) on an out-patient basis has been reported not to significantly compromise the response frequency compared to intravenous IL-2 in patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa073dc3cc4b08f0fc0ff469d8ee1fc0
https://pubmed.ncbi.nlm.nih.gov/7780487
https://pubmed.ncbi.nlm.nih.gov/7780487